Boston-based Neurable has closed a $35 million Series A funding round led by Spectrum Moonshot Fund, bringing its total funding to $65 million. The investment will accelerate the commercialization of Neurable AI, a noninvasive BCI platform that integrates brain-signal insights into consumer devices like the MW75 Neuro LT headphones for real-time focus, fatigue, and cognitive performance tracking.
Glimpse:
Neurable’s patented AI processes passive EEG data to deliver actionable brain health insights via everyday wearables and apps. The fresh capital supports expansion into gaming, e-sports, research, and enterprise applications, backed by recent partnerships with iMotions, MeSpace, and Healthspan Digital. Validated through peer-reviewed studies, the technology aims to make brain monitoring as routine as step counting amid a projected $52 billion global BCI market by 2034.
Neurable, a Boston-based leader in noninvasive brain-computer interface (BCI) technology, has raised $35 million in a Series A round to propel its vision of embedding brain insights into daily life. Led by Spectrum Moonshot Fund, the funding—announced on December 19, 2025 elevates the company’s total capital to $65 million, following a $13 million raise in 2024 from investors including Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet.
At the core is Neurable AI, a compact, patented brain-signal processing system that seamlessly integrates BCI into consumer devices without invasive implants. The flagship product, the MW75 Neuro LT headphones (developed in partnership with Master & Dynamic), features embedded EEG sensors paired with a redesigned mobile app. Users receive real-time data on mental fatigue, cognitive recovery, focus states, and distraction levels—validated across independent evaluations and peer-reviewed studies for high-fidelity detection.
This noninvasive approach democratizes neurotechnology, shifting brain health tracking from clinical labs to everyday wellness, productivity, and performance enhancement. Applications span consumer cognitive monitoring, gaming/e-sports (for concentration and endurance), enterprise research (e.g., workspace impacts on cognition), and clinical assessments.
Recent milestones underscore momentum:
Partnership with iMotions to integrate Neurable headsets into human behavior research platforms for scalable neural data capture.
Collaboration with MeSpace as official research partner studying workplace design’s effects on cognitive performance.
Alliance with Healthspan Digital to deploy BCI in global longevity clinics, starting in Dubai, for brain health evaluations.
The new funds will drive broader commercialization, deeper integrations into devices and industries, and scaling in emerging cognitive health categories.
As the global BCI market surges toward $52 billion by 2034, Neurable positions brain data as a foundational metric for work, play, and well-being much like heart rate or steps today.
“Our mission is to make understanding your brain as natural and intuitive as checking your steps. This funding allows us to scale Neurable AI into new devices and new industries, making cognitive health an accessible, daily utility for everyone.”
By
HB Team
